12 studies found for:    Open Studies | Heart Diseases | UCSD OR UC San Diego OR VA San Diego
Show Display Options
Download search resultsDownload the search results for:
Open Studies | Heart Diseases | UCSD OR UC San Diego OR VA San Diego (12 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
Conditions: Coronary Artery Disease;   Coronary Disease;   Myocardial Ischemia;   Heart Diseases;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Vascular Diseases
Intervention: Procedure: CorPath-assisted Percutaneous Coronary Intervention
2 Recruiting AC6 Gene Transfer for CHF
Condition: Congestive Heart Failure
Interventions: Drug: Ad5.hAC6;   Drug: Sucrose (3%)
3 Recruiting The Dynamics of Human Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Tachyarrhythmia
Intervention:
4 Unknown  Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
Conditions: Ranolazine;   Diastolic Heart Failure;   Tissue Doppler Ultrasound;   Echocardiography
Intervention: Drug: ranolazine
5 Recruiting An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM)
Condition: Ischemic Dilated Cardiomyopathy (IDCM)
Interventions: Biological: ixmyelocel-T;   Other: Vehicle Control
6 Recruiting Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Condition: Cardiac Arrest
Interventions: Drug: amiodarone;   Drug: Lidocaine;   Other: Normal saline
7 Recruiting Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation
Condition: Paroxysmal Atrial Fibrillation
Intervention:
8 Not yet recruiting Nit-Occlud PDA Post-Approval Study
Condition: Patent Ductus Arteriosus (PDA)
Intervention:
9 Recruiting MAESTRO (Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity)
Condition: Eisenmenger Syndrome
Interventions: Drug: Macitentan 10 mg, oral tablet, to be taken once daily.;   Drug: Matching placebo oral tablet, to be taken once daily.
10 Recruiting Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin (N-GAL) Evaluation of Symptomatic Heart Failure Study (AKINESIS)
Conditions: Acute Decompensated Heart Failure;   Acute Kidney Injury
Intervention:
11 Recruiting Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.
Condition: Smoking Cessation
Interventions: Drug: placebo;   Drug: varenicline tartrate;   Drug: bupropion hydrochloride;   Drug: Nicotine Replacement Therapy Patch
12 Recruiting Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
Condition: Portopulmonary Hypertension
Intervention: Drug: Ambrisentan

Indicates status has not been verified in more than two years